SPROGOE, KENNETT,RAU, HARALD,BERNHARD, ANA,HERSEL, ULRICH,CLEEMANN, FELIX,WEGGE, THOMAS
申请号：
CA3008015
公开号：
CA3008015A1
申请日:
2017.01.05
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to controlled-release CNP agonists having an at least 5-fold longer degradation half-life in an in vitro NEP degradation assay than the corresponding released CNP agonist, to pharmaceutical compositions comprising said controlled-release CNP agonist, their use and to methods of treatment.
